Cargando…
Five advanced pancreatic cancer patients in a Phase I study of anti-CD3 x anti-EGFR bispecific antibody armed activated T cells (BATS)
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645487/ http://dx.doi.org/10.1186/2051-1426-3-S2-P55 |
| _version_ | 1782400823669555200 |
|---|---|
| author | Lum, Lawrence G Choi, Minsig Thakur, Archana Deol, Abhinav Fields, Kristie Tomaszewski, Elyse Schalk, Dana Kondadasule, Vidya Dyson, Greg Mahaseth, Hemchandra Philip, Philip Shields, Anthony |
| author_facet | Lum, Lawrence G Choi, Minsig Thakur, Archana Deol, Abhinav Fields, Kristie Tomaszewski, Elyse Schalk, Dana Kondadasule, Vidya Dyson, Greg Mahaseth, Hemchandra Philip, Philip Shields, Anthony |
| author_sort | Lum, Lawrence G |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4645487 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-46454872015-11-20 Five advanced pancreatic cancer patients in a Phase I study of anti-CD3 x anti-EGFR bispecific antibody armed activated T cells (BATS) Lum, Lawrence G Choi, Minsig Thakur, Archana Deol, Abhinav Fields, Kristie Tomaszewski, Elyse Schalk, Dana Kondadasule, Vidya Dyson, Greg Mahaseth, Hemchandra Philip, Philip Shields, Anthony J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4645487/ http://dx.doi.org/10.1186/2051-1426-3-S2-P55 Text en Copyright © 2015 Lum et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Lum, Lawrence G Choi, Minsig Thakur, Archana Deol, Abhinav Fields, Kristie Tomaszewski, Elyse Schalk, Dana Kondadasule, Vidya Dyson, Greg Mahaseth, Hemchandra Philip, Philip Shields, Anthony Five advanced pancreatic cancer patients in a Phase I study of anti-CD3 x anti-EGFR bispecific antibody armed activated T cells (BATS) |
| title | Five advanced pancreatic cancer patients in a Phase I study of anti-CD3 x anti-EGFR bispecific antibody armed activated T cells (BATS) |
| title_full | Five advanced pancreatic cancer patients in a Phase I study of anti-CD3 x anti-EGFR bispecific antibody armed activated T cells (BATS) |
| title_fullStr | Five advanced pancreatic cancer patients in a Phase I study of anti-CD3 x anti-EGFR bispecific antibody armed activated T cells (BATS) |
| title_full_unstemmed | Five advanced pancreatic cancer patients in a Phase I study of anti-CD3 x anti-EGFR bispecific antibody armed activated T cells (BATS) |
| title_short | Five advanced pancreatic cancer patients in a Phase I study of anti-CD3 x anti-EGFR bispecific antibody armed activated T cells (BATS) |
| title_sort | five advanced pancreatic cancer patients in a phase i study of anti-cd3 x anti-egfr bispecific antibody armed activated t cells (bats) |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645487/ http://dx.doi.org/10.1186/2051-1426-3-S2-P55 |
| work_keys_str_mv | AT lumlawrenceg fiveadvancedpancreaticcancerpatientsinaphaseistudyofanticd3xantiegfrbispecificantibodyarmedactivatedtcellsbats AT choiminsig fiveadvancedpancreaticcancerpatientsinaphaseistudyofanticd3xantiegfrbispecificantibodyarmedactivatedtcellsbats AT thakurarchana fiveadvancedpancreaticcancerpatientsinaphaseistudyofanticd3xantiegfrbispecificantibodyarmedactivatedtcellsbats AT deolabhinav fiveadvancedpancreaticcancerpatientsinaphaseistudyofanticd3xantiegfrbispecificantibodyarmedactivatedtcellsbats AT fieldskristie fiveadvancedpancreaticcancerpatientsinaphaseistudyofanticd3xantiegfrbispecificantibodyarmedactivatedtcellsbats AT tomaszewskielyse fiveadvancedpancreaticcancerpatientsinaphaseistudyofanticd3xantiegfrbispecificantibodyarmedactivatedtcellsbats AT schalkdana fiveadvancedpancreaticcancerpatientsinaphaseistudyofanticd3xantiegfrbispecificantibodyarmedactivatedtcellsbats AT kondadasulevidya fiveadvancedpancreaticcancerpatientsinaphaseistudyofanticd3xantiegfrbispecificantibodyarmedactivatedtcellsbats AT dysongreg fiveadvancedpancreaticcancerpatientsinaphaseistudyofanticd3xantiegfrbispecificantibodyarmedactivatedtcellsbats AT mahasethhemchandra fiveadvancedpancreaticcancerpatientsinaphaseistudyofanticd3xantiegfrbispecificantibodyarmedactivatedtcellsbats AT philipphilip fiveadvancedpancreaticcancerpatientsinaphaseistudyofanticd3xantiegfrbispecificantibodyarmedactivatedtcellsbats AT shieldsanthony fiveadvancedpancreaticcancerpatientsinaphaseistudyofanticd3xantiegfrbispecificantibodyarmedactivatedtcellsbats |